Grape King Bio Ltd (TPE:1707)
118.50
-2.00 (-1.66%)
Mar 9, 2026, 1:35 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 17.55 billion as of March 9, 2026. Its market cap has decreased by -20.47% in one year.
Market Cap
17.55B
Enterprise Value
15.22B
Revenue
10.25B
Ranking
n/a
PE Ratio
14.50
Stock Price
118.50
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 17.55B, an increase of 655.82%. That is a compound annual growth rate of 6.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 15.92B |
| TTY Biopharm Company | 20.74B |
| YungShin Global Holding | 14.46B |
| Foresee Pharmaceuticals | 12.86B |
| Alar Pharmaceuticals | 12.83B |
| Handa Pharmaceuticals | 12.55B |
| Standard Chemical & Pharmaceutical | 11.54B |